1-15 of 15
Martin Hoffmann
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Minimal Residual Disease on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy in the Phase 3 GMMG-HD7 Trial

Elias K. Mai, Hans Salwender, Michael Hundemer, Uta Bertsch, Ema Pozek, Axel Benner, Roland Fenk, Britta Besemer, Christine Hanoun, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Lisa Leypoldt, Bernhard Heilmeier, Stefanie Huhn, Sabine Vogel, Christof Scheid, Igor Wolfgang Blau, Steffen Luntz, Niels Weinhold, Tobias A.W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Evgenii Shumilov, Wolfgang Knauf, Christian Sebastian Michel, Thomas Geer, Hendrik Riesenberg, Christoph Lutz, Marc S. Raab, Martin Hoffmann, Katja C. Weisel, Hartmut Goldschmidt
Journal: Blood
Blood (2024) 144 (Supplement 1): 364.
https://doi.org/10.1182/blood-2024-194768
Published: 2024
Journal Articles

Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy for Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma: Final Progression-Free Survival Analysis of Part 1 of an Open-Label, Multicenter, Randomized, Phase 3 Trial (GMMG-HD7)

Hartmut Goldschmidt, Uta Bertsch, Ema Pozek, Axel Benner, Roland Fenk, Britta Besemer, Christine Hanoun, Roland Schroers, Ivana von Metzler, Mathias Hänel, Christoph Mann, Lisa Leypoldt, Bernhard Heilmeier, Stefanie Huhn, Sabine Vogel, Michael Hundemer, Christof Scheid, Igor Wolfgang Blau, Steffen Luntz, Tobias A.W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Evgenii Shumilov, Wolfgang Knauf, Christian Sebastian Michel, Thomas Geer, Hendrik Riesenberg, Christoph Lutz, Marc-Steffen Raab, Martin Hoffmann, Katja C. Weisel, Hans Salwender, Elias K. Mai
Journal: Blood
Blood (2024) 144 (Supplement 1): 769.
https://doi.org/10.1182/blood-2024-193308
Published: 2024
Journal Articles

Addition of Isatuximab to Lenalidomide, Bortezomib and Dexamethasone As Induction Therapy for Newly-Diagnosed, Transplant-Eligible Multiple Myeloma Patients: The Phase III GMMG-HD7 Trial

Hartmut Goldschmidt, Elias K Mai, Eva Nievergall, Roland Fenk, Uta Bertsch, Diana Tichy, Britta Besemer, Jan Dürig, Roland Schroers, Ivana v. Metzler, Mathias Haenel, Christoph Mann, Anne-Marie Asemissen, Bernhard Heilmeier, Stefanie Huhn, Katharina Kriegsmann, Niels Weinhold, Steffen P. Luntz, Tobias A. W. Holderried, Karolin Trautmann-Grill, Deniz Gezer, Maika Klaiber-Hakimi, Martin Mueller, Cyrus Khandanpour, Wolfgang Knauf, Markus Munder, Thomas Geer, Hendrik Riesenberg, Joerg Thomalla, Martin Hoffmann, Marc-Steffen Raab, Hans Salwender, Katja Weisel
Journal: Blood
Blood (2021) 138 (Supplement 1): 463.
https://doi.org/10.1182/blood-2021-145097
Published: 2021
Journal Articles

Response-Adapted Lenalidomide Maintenance in Newly Diagnosed, Transplant-Eligible Multiple Myeloma: Results from the Multicenter Phase III GMMG-MM5 Trial

Hartmut Goldschmidt, MD, Elias K Mai, MD, Jan Dürig, MD, Christof Scheid, MD, Katja C. Weisel, Christina Kunz, Uta Bertsch, MD, Thomas Hielscher, PhD, Markus Munder, MD, Hans-Walter Lindemann, Barbara Huegle-Doerr, Dirk Hose, MD, Anja Seckinger, Stefanie Huhn, PhD, Anna Jauch, Bernhard Rabold, Ahmet Elmaagacli, MD, Christian Gerecke, MD, Peter Brossart, MD, Martin Goerner, MD, Helga Bernhard, MD, Martin Hoffmann, MD, Jens Hillengass, MD, Marc-Steffen S Raab, Igor Wolfgang Blau, MD, Mathias Hänel, MD, Hans Jürgen Salwender
Journal: Blood
Blood (2017) 130 (Supplement 1): 400.
https://doi.org/10.1182/blood.V130.Suppl_1.400.400
Published: 2017
Journal Articles

Direct Assessment of IgA and IgG Paraprotein By Hevylite Assay and Correlation to IMWG Response and Progression-Free Survival in Newly Diagnosed, Transplant-Eligible Multiple Myeloma Patients in the Prospective Phase III GMMG-MM5 Trial

Christof Scheid, MD, Anja Seckinger, Jan Dürig, MD, Katja C. Weisel, Christina Kunz, Uta Bertsch, MD, Thomas Hielscher, PhD, Markus Munder, MD, Hans-Walter Lindemann, Barbara Huegle-Doerr, Stefanie Huhn, PhD, Elias K Mai, MD, Anna Jauch, Bernhard Rabold, Christian Gerecke, MD, Peter Brossart, MD, Martin Goerner, MD, Helga Bernhard, MD, Martin Hoffmann, MD, Jens Hillengass, MD, Marc-Steffen S Raab, Igor Wolfgang Blau, MD, Mathias Haenel, Dirk Hose, MD, Hartmut Goldschmidt, MD, Hans Jürgen Salwender
Journal: Blood
Blood (2017) 130 (Supplement 1): 1784.
https://doi.org/10.1182/blood.V130.Suppl_1.1784.1784
Published: 2017
Journal Articles

Combining Information Regarding Chromosomal Aberrations t(4;14), Del(17p13) and the Copy Number of 1q21 with the International Staging System Classification Allows Stratification of Myeloma Patients Undergoing Autologous Stem Cell Transplantation: Results From the HOVON-65/GMMG HD4 Trial

Kai Neben, MD, Henk M. Lokhorst, MD, Anna Jauch, PhD, Uta Bertsch, MD, Thomas Hielscher, Christiane Heiss, Bronno van der Holt, PhD, Stefan Schmitt, Laila el Jarari, MSc, Hans J. Salwender, MD, Igor W. Blau, Michael Pfreundschuh, MD, Katja Weisel, MD, Ulrich Duehrsen, MD, Walter Lindemann, Christian Teschendorf, Hans Martin, Christof Scheid, Mathias Haenel, MD, Hans Guenter Derigs, Ullrich Graeven, Ingo GH Schmidt-Wolf, Norma Peter, Mohammed Wattad, MD, Steffen P Luntz, Annemiek Broyl, MD, Joerg Schubert, MD, Martin Hoffmann, Martin Goerner, MD, Jochen Tischler, Martin Kaufmann, MD, Marc S Raab, Anthony D. Ho, MD, Helgi van de Velde, MD, PhD, Dirk Hose, MD, Pieter Sonneveld, MD, PhD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2011) 118 (21): 332.
https://doi.org/10.1182/blood.V118.21.332.332
Published: 2011
Journal Articles

Ibandronate and Renal Function In Myeloma Patients

Raoul Bergner, Jochen Breuer, Andreas Sandermann, Michael J. Uppenkamp, Martin Hoffmann
Journal: Blood
Blood (2010) 116 (21): 5047.
https://doi.org/10.1182/blood.V116.21.5047.5047
Published: 2010
Journal Articles

Pharmacokinetics of Doxorubicin In Normal Weight and Obese Lymphoma Patients

Martin Hoffmann, Raoul Bergner, Marion Stützle, Michael J. Uppenkamp, Rabea Foerster
Journal: Blood
Blood (2010) 116 (21): 4935.
https://doi.org/10.1182/blood.V116.21.4935.4935
Published: 2010
Journal Articles

Renal Involvement and Outcome In Monoclonal Lightchain Disease

Raoul Bergner, Michael J. Uppenkamp, Martin Hoffmann
Journal: Blood
Blood (2010) 116 (21): 4985.
https://doi.org/10.1182/blood.V116.21.4985.4985
Published: 2010
Journal Articles

Bortezomib-Based Induction Therapy Followed by Autologous Stem Cell Transplantation and Maintenance Therapy with Bortezomib Improves Outcome In Myeloma Patients with Gain 1q21 and t(4;14) - a Subgroup Analysis of the HOVON-65/GMMG-HD4 Trial

Hartmut Goldschmidt, Kai Neben, Uta Bertsch, Thomas Hielscher, Bronno van der Holt, Dirk Hose, Laila el Jarari, Hans Salwender, Igor Wolfgang Blau, Michael Pfreundschuh, Ulrich Duehrsen, Katja Weisel, Hans Martin, Walter Lindemann, Christian Teschendorf, Mathias Haenel, Christof Scheid, Helgi van de Velde, Hans Guenter Derigs, Martin Hoffmann, Norma Peter, Martin Kaufmann, Ingo Schmidt-Wolf, Anna Jauch, Henk M Lokhorst, Pieter Sonneveld
Journal: Blood
Blood (2010) 116 (21): 305.
https://doi.org/10.1182/blood.V116.21.305.305
Published: 2010
Journal Articles

Phase I/II Study for the Effectivity of Rituximab, Gemcitabin and Oxaliplatin in Relapsed Indolent Lymphoma – An Interim Report.

Martin Hoffmann, Martin H. Dreyling, H.-P. Böck, Ulrich Dührsen, MD, PhD, Joachim Kaesberger, Stephan Kremers, Walter Lindemann, Luisa Mantovani, Michael J. Uppenkamp, MD, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2009) 114 (22): 3700.
https://doi.org/10.1182/blood.V114.22.3700.3700
Published: 2009
Journal Articles

Renal Safety of Ibandronate in the Treatment of Myeloma Patients.

Raoul Bergner, Jochen Breuer, Michael J. Uppenkamp, MD, Andreas Sandermann, Martin Hoffmann
Journal: Blood
Blood (2009) 114 (22): 4943.
https://doi.org/10.1182/blood.V114.22.4943.4943
Published: 2009
Journal Articles

Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Joerg Schubert, Marita Ziepert, Eva Lengfelder, PD, Martin Mohren, PD, Norma Peter, MD, Marcel Reiser, PD, Michael Clemens, Christina Nickenig, MD, Maike deWit, PD, Anthony Ho, Hartmut Eimermacher, MD, Lorenz Truemper, Martin Hoffmann, MD, Roland Mertelsmann, Bernd Metzner, MD, Hans-Guenther Mergenthaler, Ruediger Liersch, MD, Ulrich Duehrsen, Leopold Balleisen, Frank Hartmann, Viola Poeschel, Norbert Schmitz, Markus Loeffler, Michael Pfreundschuh
Journal: Blood
Blood (2007) 110 (11): 788.
https://doi.org/10.1182/blood.V110.11.788.788
Published: 2007
Journal Articles

Open-Label Study of Ibandronate in Elderly Myeloma Patients with Pre-Existing Renal Deterioration.

Dirk Henrich, Raoul Bergner, Martin Hoffmann, Andrea Honecker, Dietmar Nagel, Michael Uppenkamp
Journal: Blood
Blood (2005) 106 (11): 3459.
https://doi.org/10.1182/blood.V106.11.3459.3459
Published: 2005
Journal Articles

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Rudolf Schmits, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Hans Steinhauer, MD, Marcel Reiser, MD, Michael Clemens, MD, Christine Nickenig, MD, Martha de Wit, MD, Martin Hoffmann, MD, Roland Mertelsmann, MD, Bernd Metzner, MD, Anthony Ho, MD, Lorenz Truemper, MD, Hans Eimermacher, MD, Hans Mergenthaler, MD, Ruediger Liersch, MD, Ulrich Duehrsen, MD, Leopold Balleisen, MD, Frank Hartmann, MD, Viola Poeschel, MD, Norbert Schmitz, MD, Markus Loeffler, MD
Journal: Blood
Blood (2005) 106 (11): 13.
https://doi.org/10.1182/blood.V106.11.13.13
Published: 2005